ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 134 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,742,200 | -38.1% | 400,321 | -6.2% | 0.00% | – |
| Q2 2023 | $4,427,565 | +27.5% | 426,959 | -0.5% | 0.00% | – |
| Q1 2023 | $3,472,000 | +51443.9% | 429,167 | +0.4% | 0.00% | -100.0% |
| Q4 2022 | $6,736 | -99.9% | 427,660 | -5.6% | 0.00% | 0.0% |
| Q3 2022 | $7,129,000 | +10.6% | 452,965 | -1.9% | 0.00% | 0.0% |
| Q2 2022 | $6,444,000 | +736.9% | 461,596 | +933.8% | 0.00% | – |
| Q1 2022 | $770,000 | +42.3% | 44,650 | +20.0% | 0.00% | – |
| Q4 2021 | $541,000 | +0.9% | 37,202 | +24.7% | 0.00% | – |
| Q3 2021 | $536,000 | +14.0% | 29,826 | +11.4% | 0.00% | – |
| Q2 2021 | $470,000 | +46900.0% | 26,777 | +127409.5% | 0.00% | – |
| Q1 2021 | $1,000 | – | 21 | -43.2% | 0.00% | – |
| Q4 2020 | $0 | – | 37 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 37 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 37 | -100.0% | 0.00% | – |
| Q1 2020 | $186,000 | -52.1% | 179,081 | -12.8% | 0.00% | – |
| Q4 2019 | $388,000 | +66.5% | 205,468 | -5.0% | 0.00% | – |
| Q3 2019 | $233,000 | -73.2% | 216,252 | -47.0% | 0.00% | – |
| Q2 2019 | $870,000 | -40.9% | 408,262 | +66.1% | 0.00% | – |
| Q1 2019 | $1,472,000 | +2.6% | 245,804 | +26.6% | 0.00% | – |
| Q4 2018 | $1,435,000 | -47.5% | 194,144 | +3.1% | 0.00% | -100.0% |
| Q3 2018 | $2,735,000 | -25.6% | 188,380 | +2.4% | 0.00% | 0.0% |
| Q2 2018 | $3,675,000 | +10.3% | 184,029 | -3.3% | 0.00% | 0.0% |
| Q1 2018 | $3,333,000 | +2587.9% | 190,281 | +3694.2% | 0.00% | – |
| Q4 2017 | $124,000 | -40.1% | 5,015 | -34.2% | 0.00% | – |
| Q4 2016 | $207,000 | – | 7,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |